William Plovanic
Stock Analyst at Canaccord Genuity
(3.69)
# 763
Out of 4,754 analysts
132
Total ratings
46.49%
Success rate
7.76%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $63 | $20.78 | +203.18% | 3 | Feb 26, 2025 | |
| CBLL CeriBell | Maintains: Buy | $33 | $24.62 | +34.04% | 4 | Feb 26, 2025 | |
| DXCM DexCom | Maintains: Buy | $99 → $103 | $85.99 | +19.78% | 5 | Feb 14, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $68 → $71 | $71.39 | -0.55% | 25 | Feb 13, 2025 | |
| ATRC AtriCure | Maintains: Buy | $61 → $66 | $38.96 | +69.40% | 10 | Feb 13, 2025 | |
| NVRO Nevro | Maintains: Hold | $4 → $5.85 | $5.72 | +2.27% | 12 | Feb 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $22 → $23 | $12.35 | +86.23% | 7 | Feb 5, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $101 | $79.25 | +27.44% | 3 | Jan 10, 2025 | |
| PODD Insulet | Maintains: Buy | $269 → $304 | $272.64 | +11.50% | 3 | Dec 9, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $125 → $152 | $109.10 | +39.32% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $104.87 | -3.69% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $104 | $69.33 | +50.01% | 4 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $5.68 | +93.66% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $10.16 | +47.64% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $9.32 | +28.76% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $105.38 | +9.13% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $3 | $4.26 | -29.58% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $285.75 | -0.61% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $12.27 | +103.75% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $8.29 | +44.75% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $103.03 | -32.06% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $16.47 | +191.44% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $5.19 | +323.89% | 3 | Jul 25, 2023 |
Tandem Diabetes Care
Feb 26, 2025
Maintains: Buy
Price Target: $63
Current: $20.78
Upside: +203.18%
CeriBell
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $24.62
Upside: +34.04%
DexCom
Feb 14, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $85.99
Upside: +19.78%
Edwards Lifesciences
Feb 13, 2025
Maintains: Hold
Price Target: $68 → $71
Current: $71.39
Upside: -0.55%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $61 → $66
Current: $38.96
Upside: +69.40%
Nevro
Feb 7, 2025
Maintains: Hold
Price Target: $4 → $5.85
Current: $5.72
Upside: +2.27%
CVRx, Inc.
Feb 5, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $12.35
Upside: +86.23%
Globus Medical
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $79.25
Upside: +27.44%
Insulet
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $272.64
Upside: +11.50%
iRhythm Technologies
Dec 9, 2024
Maintains: Buy
Price Target: $125 → $152
Current: $109.10
Upside: +39.32%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $104.87
Upside: -3.69%
Nov 20, 2024
Maintains: Buy
Price Target: $109 → $104
Current: $69.33
Upside: +50.01%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $11
Current: $5.68
Upside: +93.66%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $10.16
Upside: +47.64%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.32
Upside: +28.76%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $105.38
Upside: +9.13%
Aug 13, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $4.26
Upside: -29.58%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $285.75
Upside: -0.61%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $12.27
Upside: +103.75%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $8.29
Upside: +44.75%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $103.03
Upside: -32.06%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $16.47
Upside: +191.44%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $5.19
Upside: +323.89%